NAD+ source due diligence
NAD+ research source checklist Canada
A Canadian RUO checklist for evaluating NAD+ source pages: chemical identity as nicotinamide adenine dinucleotide, the displayed lot COA, assay method, stated fill, storage notes, and claim boundaries.
Route NAD+ demand into a source record
NAD+ Canada searches are compound-specific, but the useful next step is still documentation: exact chemical identity as nicotinamide adenine dinucleotide, the current lot and batch record, COA access, assay method, stated fill, storage notes, Canadian fulfillment context, and a saved URL before an order is considered.
Keep NAD+ chemically distinct from peptides
NAD+ is a central redox cofactor and signalling substrate, not a peptide. It belongs in its own source file, separate from mitochondrial peptides such as SS-31 and MOTS-c and from longevity-related tetrapeptides such as Epitalon. Identity, mechanism lane, analytical evidence, and handling assumptions differ; similar catalogue placement is not evidence of equivalence.
NAD+ certificate checkpoint: 22 October 2026
The linked certificate labels the sample NAD+ 100 mg and identifies lot LNX-2602-1106 (printed with a leading #). It reports 99.66% purity, a detected quantity of 102.82 mg, batch tested 2026-02-05, received 2026-02-16, reported 2026-02-23, and an appearance of white lyophilized powder. The certificate states the results are valid for lot LNX-2602-1106 only and that the analysis applies to the sample(s) submitted. The detected quantity is a reported sample result, not a guaranteed quantity for every vial.
Match the certificate label to the listed fill
The certificate names the sample as NAD+ 100 mg, while the current catalog lists a 500 mg variant. This checklist preserves both labels without reconciling them. If your research requires a specific fill or label, request clarification that the certificate you are matching covers the exact variant you intend to procure.
Read the method labels without filling in gaps
The analytical heading states HPLC-UV coupled with mass spectrometry and the footer describes LC-MS/MS under standard laboratory conditions. This checklist preserves both labels without reconciling them or independently validating the results. Request the original analytical files and method details where institutional acceptance depends on the exact technique.
Re-check the trail when the lot changes
A familiar product name does not make a replacement lot equivalent. Re-open the product page, match the displayed batch reference to the current certificate, confirm the stated fill, purity method, and storage language, and save any support clarification with the procurement record before returning to checkout.
What this page cannot establish
- The certificate states that its results apply only to the named lot and sample. This dated checkpoint does not document a replacement lot, the 500 mg variant, or other materials.
- A reported purity percentage is not a sterility or endotoxin result, clinical approval, or evidence of suitability for administration. This material is for laboratory research only, not human or animal use.
- Lynx Labs branding and its quality-assurance contact do not establish an independent testing laboratory. Request laboratory identity, accreditation and original analytical records where required.
- The COA checklist tool can flag missing fields but cannot authenticate a document, resolve its method labels, or replace laboratory verification.
Sources and verification paths
Use these records to verify identity and current documentation. Re-check live product records when the lot or variant changes.
Research-use-only FAQ
Where can I buy NAD+ for research in Canada?
Lynx Labs lists NAD+ as a research-use-only material and ships from Canada. Review the live record at /products/nad-plus and verify the displayed lot and certificate (lot LNX-2602-1106, certificate-reported 99.66% purity for the tested sample) before ordering. Not for human or animal use.
Does the displayed NAD+ certificate verify the current 500 mg variant?
The linked certificate labels the sample NAD+ 100 mg, identifies lot LNX-2602-1106, and reports 99.66% purity and 102.82 mg detected quantity for that sample. The live catalog lists a 500 mg variant. Those labels are not interchangeable; match the certificate to the exact variant and received vial, and request clarification before procurement.
Is NAD+ the same as SS-31, MOTS-c, or Epitalon?
No. NAD+ is a redox cofactor and signalling substrate, not a peptide, while SS-31, MOTS-c, and Epitalon are peptides in different research lanes. Their chemical identity, mechanism, and analytical records are not interchangeable; keep each in its own source file.
Is this a NAD+ use guide?
No. This page is limited to research-use-only source evaluation: chemical identity, the displayed lot certificate, assay method, stated fill, storage notes, Canadian fulfillment, and claim-boundary review. It is not wellness advice, personal-use guidance, dosing information, or treatment information.
What should be saved before comparing NAD+ source pages?
Save the current product URL, exact material name and chemical identity, stated fill and variant label, visible lot or batch reference, certificate path, purity method, storage language, support clarification if needed, and the date the record was checked.
Ready to inspect current records?
LynxLabs product pages are for research-use-only procurement review. They are not dosing guides, treatment recommendations, or personal-use protocols.
Shop now